Gilead UK and Ireland 2024 Oncology Fellowship and Medical Grants Programme is now open
Subject header: Gilead UK and Ireland Oncology Fellowship and Medical Grants Programme is now open
=========
We wanted to bring your attention to an opportunity provided by Gilead UK & Ireland Oncology Fellowship and Medical Grants Programme, which is now accepting applications.
The GFP is a medical grants programme looking to support projects and initiatives which aspire to improve oncology care. GFP funding can be used to support a variety of projects including, but not limited to:
- Audits or registry reviews assessing patient profiles, disease outcomes and treatment patterns
- Setting up new infrastructure for better diagnosis or detection of disease, or prediction or monitoring of safety and efficacy outcomes to treatment including increased disease awareness in primary care and amongst members of the public
- Establishing novel patient support programmes or tools
- New protocols to facilitate improved efficiency in patient care pathways
- Frameworks to improve monitoring of patient-reported outcome measures or quality of life instruments or educational tools for patients and carers
Projects designed to tackle inequalities in cancer care amongst patient groups with poorer outcomes and/or access to care are particularly welcome. Priority will be given to those projects that focus on solid tumours particularly patients with breast cancer.
If a project that falls outside of this scope but will add clinical value or will investigate an area of unmet need in the field of oncology, you may still apply. All applications will be appraised based on their individual merit and focus on driving positive change in patient care.
The application window will close on 16th August 2024.
If you are interested in learning more about the GFP or the application process, or to check if your project is eligible for a grant and apply, please visit the Gilead UK and Ireland website.
Should you have any questions regarding the process, or the application itself, please email: [email protected]
This article and the Gilead UK & Ireland Oncology Fellowship and Medical Grants Programme have been organised and funded by Gilead Sciences.
UK-UNB-5707 Date of preparation: June 2024
